Amgen (AMGN) Stock Buyback History
TTM buyback yield N/A.
Amgen
AMGN
TTM buyback yield
N/A
Shareholder yield (TTM)
N/A
5Y share count change
-8.1%
TTM buyback spend
N/A
SBC coverage (TTM)
0.00x
Diluted vs basic shares (annual)
Weighted average shares from the income statement: diluted (EPS denominator and typical buyback-yield basis) compared with basic.
Shares outstanding (annual)
Year-over-year change in diluted weighted average shares (industry-standard for EPS and per-share capital return). Green is fewer shares vs the prior fiscal year; red is growth (dilution). The earliest year shown has no prior year to compare.
Dividend & buyback yield
Buybacks vs stock-based compensation
TTM coverage: 0.00x (buybacks ÷ SBC). Bars are fiscal-year totals.
Buyback spending history
| Year | Buybacks | SBC | Net | Shares (dil.) | YoY shares | Buyback yield |
|---|---|---|---|---|---|---|
| 2025 | $0.00 | $0.00 | $0.00 | 0.54B | 0.2% | — |
| 2024 | $200.00M | $530.00M | −$330.00M | 0.54B | 0.6% | 0.14% |
| 2023 | $0.00 | $431.00M | −$431.00M | 0.54B | -0.6% | — |
| 2022 | $6.36B | $401.00M | $5.96B | 0.54B | -5.6% | 4.53% |
| 2021 | $4.97B | $341.00M | $4.63B | 0.57B | -2.9% | 3.93% |
| 2020 | $3.49B | $330.00M | $3.16B | 0.59B | -3.1% | 2.61% |
| 2019 | $7.70B | $308.00M | $7.39B | 0.61B | -8.4% | 5.39% |
| 2018 | $17.79B | $311.00M | $17.48B | 0.67B | -9.5% | 14.39% |
| 2017 | $3.16B | $329.00M | $2.83B | 0.73B | -2.5% | 2.51% |
| 2016 | $2.96B | $311.00M | $2.65B | 0.75B | -1.6% | 2.73% |
| 2015 | $1.87B | $322.00M | $1.54B | 0.77B | -0.5% | 1.53% |
| 2014 | $138.00M | $408.00M | −$270.00M | 0.77B | 0.7% | 0.11% |
| 2013 | $832.00M | $403.00M | $429.00M | 0.77B | -2.8% | 0.97% |
| 2012 | $4.61B | $362.00M | $4.25B | 0.79B | -13.7% | 7.00% |
| 2011 | $8.31B | $341.00M | $7.97B | 0.91B | -5.5% | 16.37% |
| 2010 | $3.79B | $353.00M | $3.43B | 0.96B | -5.5% | 7.39% |
| 2009 | $3.21B | $284.00M | $2.92B | 1.02B | -5.0% | 5.77% |
| 2008 | $2.27B | $0.00 | $2.27B | 1.07B | -4.3% | 3.81% |
| 2007 | $5.10B | $0.00 | $5.10B | 1.12B | -5.6% | 10.08% |
| 2006 | $2.00B | $0.00 | $2.00B | 1.19B | -5.4% | 2.51% |
| 2005 | $4.43B | $0.00 | $4.43B | 1.26B | -4.7% | 4.67% |
| 2004 | $4.07B | $0.00 | $4.07B | 1.32B | -1.9% | 5.08% |
| 2003 | $1.80B | $0.00 | $1.80B | 1.35B | 16.7% | 2.28% |
| 2002 | $1.42B | $0.00 | $1.42B | 1.15B | 6.4% | 2.28% |
| 2001 | $737.50M | $0.00 | $737.50M | 1.08B | -0.0% | 1.25% |
| 2000 | $799.90M | $0.00 | $799.90M | 1.08B | 0.6% | — |
| 1999 | $1.02B | $0.00 | $1.02B | 1.08B | 2.0% | — |
| 1998 | $912.10M | $0.00 | $912.10M | 1.06B | -3.7% | — |
| 1997 | $737.90M | $0.00 | $737.90M | 1.10B | -2.2% | — |
| 1996 | $450.00M | $0.00 | $450.00M | 1.12B | — | — |
| 1995 | $285.70M | $0.00 | $285.70M | — | — | — |
| 1994 | $300.50M | $0.00 | $300.50M | — | — | — |
| 1993 | $207.50M | $0.00 | $207.50M | — | — | — |
| 1992 | $85.90M | $0.00 | $85.90M | — | — | — |
| 1991 | $0.00 | $0.00 | $0.00 | — | — | — |
| 1990 | $0.00 | $0.00 | $0.00 | — | — | — |
| 1989 | $0.00 | $0.00 | $0.00 | — | — | — |
| 1988 | $0.00 | $0.00 | $0.00 | — | — | — |
Buybacks vs dividends (share of cash returned)
Buyback capacity (TTM)
TTM buybacks vs headroom (FCF − dividends, TTM)0% of headroom
Headroom $2.98B (TTM FCF − TTM dividends, clamped at zero).
Frequently asked questions
Does Amgen buy back its own stock?
- Yes, Amgen (AMGN) has repurchased shares in recent periods. See the history table and charts on this page for amounts and trends.
Is Amgen diluting shareholders?
- Compare stock-based compensation (SBC) to buybacks in the chart above. Net effect varies by year; see annual buyback vs SBC bars and the history table.
How has Amgen's share count changed?
- Diluted weighted average shares changed by about -8.1% over roughly five fiscal years (annual income statement data).